(Q37448118)

20 August 2017

1 reference

title

Adverse events in bevacizumab and chemotherapy: patient management (English)

1 reference

20 August 2017

1 reference

1 reference

1 reference

Elaine Blowers

1

1 reference

20 August 2017

Kate Hall

series ordinal

2

1 reference

20 August 2017

publication date

1 April 2009

1 reference

British Journal of Nursing

20 August 2017

published in

1 reference

20 August 2017

volume

18

1 reference

20 August 2017

issue

7

1 reference

20 August 2017

page(s)

424-428

1 reference

Adverse effects of bevacizumab and their management in solid tumors

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Managing adverse events in the use of bevacizumab and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

High frequency of LMAN1 abnormalities in colorectal tumors with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

Bevacizumab for patients with metastatic renal cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.12968%2FBJON.2009.18.7.41657

10.12968/BJON.2009.18.7.41657

21 January 2018

Identifiers

DOI

0 references

1 reference